Brain energy metabolism is activated after acute and chronic administration of fenproporex in young rats

International Journal of Developmental Neuroscience

Volumn 29, Issue 8, 2011, Pages 937-942

  Rezin, Gislaine T ^a,b   Jeremias, Isabela C ^a,b   Ferreira, Gabriela K ^a,b   Cardoso, Mariane R ^a,b   Morais, Meline O S ^a,b   Gomes, Lara M ^a,b   Martinello, Otaviana B ^a,b   Valvassori, Samira S ^a,b   Quevedo, João ^a,b   Streck, Emilio L ^a,b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b Instituto Nacional de Ciência e Tecnologia Translacional em Medicina   (Brazil)

Author keywords

Fenproporex; Mitochondrial dysfunction; Obesity

Indexed keywords

CITRATE SYNTHASE; CREATINE KINASE; CYTOCHROME C OXIDASE; FENPROPOREX; MALATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ENERGY METABOLISM; BRAIN METABOLISM; CHEMICAL PARAMETERS; CHRONIC DRUG ADMINISTRATION; CITRIC ACID CYCLE; CONTROLLED STUDY; DECAPITATION; ENERGY METABOLISM; ENZYME ACTIVITY; JUVENILE ANIMAL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; AMPHETAMINES; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CITRATE (SI)-SYNTHASE; CITRIC ACID CYCLE; CREATINE KINASE; ELECTRON TRANSPORT; ENERGY METABOLISM; HUMANS; MALATE DEHYDROGENASE; MALE; OBESITY; RATS; RATS, WISTAR; SUCCINATE DEHYDROGENASE;

ANIMALIA; RATTUS;

EID: 80455173998     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2011.06.007     Document Type: Article

References (50)

1. Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid. Redox Signal. 2005, 7:1140-1149.
2. Andres R.H., Ducray A.D., Schlattner U., Wallimann T., Widmer H.R. Functions and effects of creatine in the central nervous system. Brain Res. Bull. 2008, 76:329-343.
3. Andreu A.L., Arbos M.A., Perez-Martos A., Lopez-Perez M.J., Asin J., Lopez N., Montoya J., Schwartz S. Reduced mitochondrial DNA transcription in senescent rat heart. Biochem. Biophys. Res. Commun. 1998, 252:577-581.
4. Arnaiz S.L., Coronel M.F., Boveris A. Nitric oxide, superoxide and hydrogen peroxide production in brain mitochondria after haloperidol treatment. Nitric Oxide 1999, 3:235-243.
5. Brandon C.L., Steiner H. Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum. Eur. J. Neurosci. 2003, 18:1584-1592.
6. Bray G.A., Champagne C.M. Beyond energy balance: there is more to obesity than kilocalories. J. Am. Diet. Assoc. 2005, 105:S17-S23.
7. Bray G.A., Tartaglia L.A. Medicinal strategies in the treatment of obesity. Nature 2000, 404:672-677.
8. Calabrese V., Scapagnini G., Giuffrida-Stella A.M., Bates T.E., Clark J.B. Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem. Res. 2001, 26:739-764.
9. Cassina A., Radi R. Differential inhibitory Aation of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch. Biochem. Biophys. 1996, 328:309-316.
10. Chase T.D., Brown R.E., Carrey N., Wilkinson M. Daily methylphenidate administration attenuates c-fos expression in the striatum of prepubertal rats. Neuroreport 2003, 14:769-772.
11. Cody J.T., Valtier S., Stillman S. Amphetamine and fenproporex levels following multidose administration of fenproporex. J. Anal. Toxicol. 1999, 23:187-194.
12. Cohen P.A. Imported fenproporex-based diet pills from Brazil: a report of two cases. J. Gen. Intern. Med. 2009, 24:430-433.
13. Corrêa C., Amboni G., Assis L.C., Martins M.R., Kapczinski F., Streck E.L., Quevedo J. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:887-891.
14. Coutts R.T., Nazarali A.J., Baker G.B., Pasutto F.M. Metabolism and disposition of N-(2-cyanoethyl)-amphetamine (fenproporex) and amphetamine: study in the rat brain. Can. J. Physiol. Pharmacol. 1986, 64:724-728.
15. Crowe S., Turpin S.M., Ke F., Kemp B.E., Watt M.J. Metabolic remodeling in adipocytes promotes ciliary neurotrophic factor-mediated fat loss in obesity. Endocrinology 2008, 149:2546-2556.
16. Cunha-Oliveira T., Rego A.C., Cardoso S.M., Borges F., Swerdlow R.H., Macedo T., de Oliveira C.R. Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine. Brain Res. 2006, 1089:44-54.
17. Fattal O., Budur K., Vaughan A.J., Franco K. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 2006, 47:1-7.
18. Federici M., Geracitano R., Bernardi G., Mercuri N.B. Actions of methylphenidate on dopaminergic neurons of the ventral midbrain. Biol. Psychiatry 2005, 57:361-365.
19. Fischer J.C., Ruitenbeek W., Berden J.A. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin. Chim. Acta 1985, 153:23-26.
20. Fukui R., Svenningsson P., Matsuishi T., Higashi H., Nairn A.C., Greengard P., Nishi A. Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice. J. Neurochem. 2003, 87:1391-1401.
21. Halliwell B. Free radicals, proteins and DNA: oxidative damage versus redox regulation. Biochem. Soc. Trans. 1996, 24:1023-1027.
22. Han J.C., Lawlor D.A., Kimm S.Y.S. Childhood obesity-2010: progress and challenges. Lancet 2010, 375:1737-1748.
23. Horn D., Barrientos A. Mitochondrial copper metabolism and delivery to cytochrome c oxidase. IUBMB Life 2008, 60:421-429.
24. Hughes B.P. A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathologic sera. Clin. Chim. Acta 1962, 7:597-604.
25. Husson I., Mesples B., Medja F., Leroux P., Kosofsky B., Gressens P. Methylphenidate and MK-801, an N-methyl-d-aspartate receptor antagonist: shared biological properties. Neuroscience 2004, 125:163-170.
26. Jimenez A., Jorda E.G., Verdaguer E., Pubill D., Sureda F.X., Canudas A.M., Escubedo E., Camarasa J., Camins A., Pallas M. Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol. Appl. Pharmacol. 2004, 196:223-234.
27. Kelly D., Gordon J., Alpers R., Strauss A.W. The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins. Medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase. J. Biol. Chem. 1989, 264:18921-18925.
28. Kitto G.B. Intra- and extramitochondrial malate dehydrogenases from chicken and tuna heart. Methods Enzymol. 1969, XIII:106-116.
29. Kolb B., Gorny G., Li Y., Samaha A.N., Robinson T.E. Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10523-10528.
30. Kraemer T., Theis G.A., Weber A.A. Studies on the metabolism and toxicological detection of the amphetamine-like anorectic fenproporex in human urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay. J. Chromatogr. B 2000, 738:107-118.
31. Lowry O.H., Rosebough N.G., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
32. Madrigal J.L.M., Olivenza R., Moro M.A., Lizasoain I., Lorenzo P., Rodrigo J., Leza J.C. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 2001, 24:420-429.
33. Mague S.D., Andersen S.L., Carlezon W.A. Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats. Biol. Psychiatry 2005, 57:120-125.
34. Mattei R., Carlini E.A. A comparative study of the anorectic and behavioral effects of fenproporex on male and female rats. Braz. J. Med. Biol. Res. 1996, 29:1025-1030.
35. Navarro A., Boveris A. The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 2007, 292:670-686.
36. Oliveira M.T., Rego A.C., Macedo T.R., Oliveira C.R. Drugs of abuse induce apoptotic features in PC12 cells. Ann. N. Y. Acad. Sci. 2003, 1010:667-670.
37. Pélisser-Alicot A.L., Piercecchi-Marti M., Bartoli C., Kuhlmann E., Coiffait P.E., Sanvoisin A., Giocanti D., Léonetti G. Abusive prescription of psychostimulants: a study of two cases. J. Forensic Sci. 2006, 51:407-410.
38. Penner M.R., McFadyen M.P., Pinaud R., Carrey N., Robertson H.A., Brown R.E. Age-related distribution of c-fos expression in the striatum of CD-1 mice after acute methylphenidate administration. Brain Res. Dev. Brain Res. 2002, 135:71-77.
39. Petersen K.F., Dufour S., Befroy D., Garcia R., Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 2004, 350:664-671.
40. Quigley J.E., Elmarakby A.A., Knight S.F., Manhiani M.M., Stepp D.W., Olearzcyk J.J., Imig J.D. Obesity-induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension. Clin. Exp. Pharmacol. Physiol. 2009, 36:724-728.
41. Raj M., Kumar R.K. Obesity in children & adolescents. Indian J. Med. Res. 2010, 132:598-607.
42. Ritov V.B., Menshikova E.V., He J., Ferrell R.E., Goodpaster B.H., Kelley D.E. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005, 54:8-14.
43. Rodrigues A.M., Radominski R.B., Suplicy H.L., De Almeida S.M., Niclewicz P.A., Boguszewski C.L. The cerebrospinal fluid/serum leptin ratio during pharmacological therapy for obesity. J. Clin. Endocrinol. Metab. 2002, 87:1621-1626.
44. Rustin P., Chretien D., Bourgeron T., Gérard B., Rötig A., Saudubray J.M., Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 1994, 228:35-51.
45. Shepherd D., Garland P.B. The kinetic properties of citrate synthase from rat liver mitochondria. Biochem. J. 1969, 114:597-610.
46. Streck E.L., Amboni G., Scaini G., Di-Pietro P.B., Rezin G.T., Valvassori S.S., Luz G., Kapczinski F., Quevedo J. Brain creatine kinase activity in an animal model of mania. Life Sci. 2008, 82:424-429.
47. Tyler D. The Mitochondrion in Health and Diseases 1992, VCH Publishers, New York.
48. Valvassori S.S., Petronilho F.C., Réus G.Z., Steckert A.V., Oliveira V.B., Boeck C.R., Kapczinski F., Dal-Pizzol F., Quevedo J. Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1064-1068.
49. Valvassori S.S., Rezin G.T., Ferreira C.L., Moretti M., Gonçalves C.L., Cardoso M.R., Streck E.L., Kapczinski F., Quevedo J. Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. J. Psychiatr. Res. 2010, 44:903-909.
50. Yeh S.Y. Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats. Pharmacol. Biochem. Behav. 1997, 58:701-708.